Depletion of PRPF19 expression resulted in the anticipated sensitization to temozolomide in glioblastoma cell lines and primary cell cultures, and may therefore, be investigated further as a predictive marker in MGMT promoter unmethylated glioblastoma. The gene discussed is MGMT; the disease is glioblastoma.